Literature DB >> 7831707

Embolic stroke following thrombolytic therapy for myocardial infarction in a patient with preexisting ventricular thrombi.

R E Bautista1.   

Abstract

BACKGROUND: Dislodging of preexisting cardiac thrombi has been a reported but unconfirmed cause of embolic strokes after thrombolytic therapy for myocardial infarction. CASE DESCRIPTION: An 82-year-old woman was admitted with congestive heart failure. Initial echocardiogram demonstrated ventricular thrombi. Three days later she experienced an inferior wall myocardial infarction, and intravenous streptokinase was administered. Six hours later she abruptly developed a global aphasia with a dense right hemiparesis. Repeat echocardiogram did not show any thrombus.
CONCLUSIONS: Thrombolytic therapy may have caused embolization of ventricular thrombi. Cardiac conditions that predispose to embolic strokes are not established contraindications to thrombolytic therapy. The potential for thrombolytic therapy to produce embolization in patients with preexisting cardiac mural thrombi should be evaluated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7831707     DOI: 10.1161/01.str.26.2.324

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Recurrent artery-to-artery embolism during intravenous t-PA therapy for acute ischemic stroke.

Authors:  Christopher D Anderson; Deborah L Bergman; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Intravenous thrombolysis of occlusion in the middle cerebral and retinal arteries from presumed ventricular myxoma.

Authors:  Cheung-Ter Ong; Rei-Yeuh Chang
Journal:  Stroke Res Treat       Date:  2010-12-02

3.  Strength and deformability of fibrin clots: Biomechanics, thermodynamics, and mechanisms of rupture.

Authors:  Valerie Tutwiler; Farkhad Maksudov; Rustem I Litvinov; John W Weisel; Valeri Barsegov
Journal:  Acta Biomater       Date:  2021-07-05       Impact factor: 10.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.